Summary and conclusions A double-blind study was conducted to test the prophylactic effect of a single dose of co-trimoxazole on the incidence of septic complications after elective cholecystectomy. Forty-eight patients received co-trimoxazole and 47 placebo. Wound sepsis occurred in 10 (21%) of the controls but in only 2 (4%) of the treated group, and the incidences of pulmonary complications were 49% (23 cases) and 19% (9) respectively. These differences were significant.
Introduction
Infective complications after biliary surgery are common. Some 30% of patients undergoing cholecystectomy have positive bile cultures' ; 20% develop a wound infection.2 3 There is a close correlation between the presence of bacteria in the bile and wound sepsis.4 Patients particularly at risk include the elderly, patients with stones in the common bile duct, and those undergoing emergency surgery.5 6 Pulmonary complications are also common after cholecystectomy.7 8 10 ml co-trimoxazole (equivalent to 160 mg trimethoprim plus 800 mg sulphamethoxazole) in 250 ml physiological saline by intravenous infusion over 60 minutes before operation. The control group received 250 ml physiological saline only. The choice of abdominal incision, technique of cholecystectomy, and type of drainage used was at the discretion of the surgeon. Patients with obstructive jaundice were not included.
Samples of bile and venous blood were obtained at operation for bacteriological and co-trimoxazole assay. One observer (CM), who was unaware of which treatment the patients received, monitored the wounds daily. Wound sepsis was defined as the presence of pus, either discharging spontaneously or requiring drainage.9 Sepsis at drain sites was not included. Wound swabs were obtained when clinically indicated. Antibiotics were given postoperatively at the discretion of the clinician.
In addition, the incidence of pulmonary complications was assessed on the basis of cough, production of purulent sputum, persistently raised temperature, physical signs, and a routine chest radiograph on the third postoperative day.
Bacteriological specimens were cultured aerobically and anaerobically for 48 hours with 10%/' added carbon dioxide. Culture media used for bile and wound exudates were: 6% horse-blood agar, 6%o 
Discussion
These results show trimoxazole significantly elective cholecystectomy. patients with infected bile. The choice of antibiotic for prophylactic use is therefore governed by the organisms found in the biliary tree, predominantly coliforms and streptococci. Fewer than half of these organisms are now sensitive to ampicillin and tetracycline.2 We find that the cephalosporin antibiotics are only marginally more effective. The widespread use of gentamicin as a routine prophylactic antibiotic has theoretical disadvantages. It is not effective against streptococci; while highly effective against coliform bacilli, extensive prophylactic use with attendant dangers of emerging resistance may diminish its usefulness in life-threatening sepsis. In contrast, co-trimoxazole is a safe, non-toxic antibiotic; after intravenous infusion it rapidly achieves high plasma concentrations, which persist for several hours. It is effective against the common biliary pathogens.
Our results show that adequate plasma concentrations of trimethoprim and sulphamethoxazole were achieved. Keighley argued that plasma concentrations are more important than bile concentrations in that gentamicin, which achieves good plasma concentrations but is poorly excreted in bile, reduces wound sepsis.13 Rifamide on the other hand can reach high concentrations in bile, but if plasma concentrations are not adequate this antibiotic is ineffective." Our studies have shown that trimethoprim but not sulphamethoxazole was concentrated in the bile of patients with radiologically functioning gall bladders, thereby altering the ratio of one part trimethoprim to 20 parts sulphamethoxazole in plasma to a 1:1 ratio. The significance of this in vivo is not clear, but it was in this group that the greatest fall in wound sepsis occurred. There may therefore be merit in using an antimicrobial agent that attains therapeutic concentrations in both plasma and bile. In our study co-trimoxazole also reduced the incidence of pulmonary complications after cholecystectomy. Indeed, it appears to have an effect on postoperative chest complications somewhat similar to that on wound infection. Haemophilus influenzae and Str pneumoniae are the common pathogens involved. Both are highly sensitive to co-trimoxazole and, interestingly, a single dose of co-trimoxazole appeared to provide clinical benefit. This finding is particularly relevant for patients with chronic respiratory disease and warrants further investigation.
The reduction in wound sepsis achieved with co-trimoxazole was significant. Only patients liable to have pathogenic bacteria in their bile at operation have been thought to require antibiotic cover.2 7 Several methods have been described whereby such patients might be recognised. These include identifying risk factors, using duodenal intubation, and intraoperative Gram staining.2 Few centres, however, have time and resources for these measures. A single dose of co-trimoxazole covering the operative period provides a practical alternative. This reduces not only wound sepsis but also pulmonary complications.
Introduction
Biguanides affect lactate metabolism,' and severall 2 but not all3 workers have found that phenformin is more potent than metformin. In most reported cases of lactic acidosis the patients had been treated with phenformin; few had received metformin or buformin.1 This may reflect differences in the use of the drugs rather than true pharmacological differences. A sixfold variation was found in the total use of biguanides in seven European countries.4 Phenformin was the most-prescribed biguanide in five of these.
In our study, carried out in Sweden, we attempted to relate reports of adverse reactions (ADRs) to phenformin and metformin (the two biguanides sold in Sweden) to sales and prescription data.
Materials and methods
All reports sent to the Swedish Adverse Drug Reaction Committee are scrutinised by a medical officer, discussed by a working party, and settled by the full committee.5 In severe cases the complete medical record is obtained. The following classification is used by the committee: causal relation "probable," "not excluded," or "unlikely," or insufficient information available. Only one adverse reaction per person (the most severe) was included in this study. In 1975 it became obligatory to report suspicions of ADRs to drugs that were fatal or
